The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insomnia Therapeutics Drugs-Global Market Insights and Sales Trends 2025
Synopsis
The global Insomnia Therapeutics Drugs market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Therapeutics Drugs in various end use industries. The expanding demands from the Prescription and Over-the-Counter (OTC), are propelling Insomnia Therapeutics Drugs market. Benzodiazepines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonbenzodiazepines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Therapeutics Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Therapeutics Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Therapeutics Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Therapeutics Drugs covered in this report include Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi and Paratek Pharmaceuticals Inc., etc.
The global Insomnia Therapeutics Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Global Insomnia Therapeutics Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Therapeutics Drugs market, Segment by Type:
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Global Insomnia Therapeutics Drugs market, by Application
Prescription
Over-the-Counter (OTC)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Therapeutics Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Insomnia Therapeutics Drugs market size is expected to reach US$ 3710.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia Therapeutics Drugs in various end use industries. The expanding demands from the Prescription and Over-the-Counter (OTC), are propelling Insomnia Therapeutics Drugs market. Benzodiazepines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonbenzodiazepines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia Therapeutics Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia Therapeutics Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia Therapeutics Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia Therapeutics Drugs covered in this report include Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi and Paratek Pharmaceuticals Inc., etc.
The global Insomnia Therapeutics Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Global Insomnia Therapeutics Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia Therapeutics Drugs market, Segment by Type:
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Global Insomnia Therapeutics Drugs market, by Application
Prescription
Over-the-Counter (OTC)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia Therapeutics Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Insomnia Therapeutics Drugs
1.1 Insomnia Therapeutics Drugs Market Overview
1.1.1 Insomnia Therapeutics Drugs Product Scope
1.1.2 Insomnia Therapeutics Drugs Market Status and Outlook
1.2 Global Insomnia Therapeutics Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Insomnia Therapeutics Drugs Market Size by Region (2018-2029)
1.4 Global Insomnia Therapeutics Drugs Historic Market Size by Region (2018-2023)
1.5 Global Insomnia Therapeutics Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Insomnia Therapeutics Drugs Market Size (2018-2029)
1.6.1 North America Insomnia Therapeutics Drugs Market Size (2018-2029)
1.6.2 Europe Insomnia Therapeutics Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2018-2029)
1.6.4 Latin America Insomnia Therapeutics Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2018-2029)
2 Insomnia Therapeutics Drugs Market by Type
2.1 Introduction
2.1.1 Benzodiazepines
2.1.2 Nonbenzodiazepines
2.1.3 Antidepressants
2.1.4 Orexin Antagonists
2.1.5 Melatonin Antagonists
2.1.6 Others
2.2 Global Insomnia Therapeutics Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Insomnia Therapeutics Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Insomnia Therapeutics Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Insomnia Therapeutics Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Insomnia Therapeutics Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Insomnia Therapeutics Drugs Revenue Breakdown by Type (2018-2029)
3 Insomnia Therapeutics Drugs Market Overview by Application
3.1 Introduction
3.1.1 Prescription
3.1.2 Over-the-Counter (OTC)
3.2 Global Insomnia Therapeutics Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Insomnia Therapeutics Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Insomnia Therapeutics Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Insomnia Therapeutics Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Insomnia Therapeutics Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Insomnia Therapeutics Drugs Revenue Breakdown by Application (2018-2029)
4 Insomnia Therapeutics Drugs Competition Analysis by Players
4.1 Global Insomnia Therapeutics Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2022)
4.3 Date of Key Players Enter into Insomnia Therapeutics Drugs Market
4.4 Global Top Players Insomnia Therapeutics Drugs Headquarters and Area Served
4.5 Key Players Insomnia Therapeutics Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Therapeutics Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda Pharmaceutical Company Ltd.
5.1.1 Takeda Pharmaceutical Company Ltd. Profile
5.1.2 Takeda Pharmaceutical Company Ltd. Main Business
5.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions
5.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.2 Vanda Pharmaceuticals
5.2.1 Vanda Pharmaceuticals Profile
5.2.2 Vanda Pharmaceuticals Main Business
5.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Products, Services and Solutions
5.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Vanda Pharmaceuticals Recent Developments
5.3 Merck & Co., Inc.
5.3.1 Merck & Co., Inc. Profile
5.3.2 Merck & Co., Inc. Main Business
5.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Products, Services and Solutions
5.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Inc. Recent Developments
5.4 Pfizer Inc.
5.4.1 Pfizer Inc. Profile
5.4.2 Pfizer Inc. Main Business
5.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Products, Services and Solutions
5.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Inc. Recent Developments
5.5 Teva Pharmaceutical Industries Ltd.
5.5.1 Teva Pharmaceutical Industries Ltd. Profile
5.5.2 Teva Pharmaceutical Industries Ltd. Main Business
5.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions
5.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.6 Mylan N.V.
5.6.1 Mylan N.V. Profile
5.6.2 Mylan N.V. Main Business
5.6.3 Mylan N.V. Insomnia Therapeutics Drugs Products, Services and Solutions
5.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Mylan N.V. Recent Developments
5.7 Sumitomo Dainippon Pharma Co., Ltd
5.7.1 Sumitomo Dainippon Pharma Co., Ltd Profile
5.7.2 Sumitomo Dainippon Pharma Co., Ltd Main Business
5.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Products, Services and Solutions
5.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Insomnia Therapeutics Drugs Products, Services and Solutions
5.8.4 Sanofi Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Paratek Pharmaceuticals Inc.
5.9.1 Paratek Pharmaceuticals Inc. Profile
5.9.2 Paratek Pharmaceuticals Inc. Main Business
5.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Products, Services and Solutions
5.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Paratek Pharmaceuticals Inc. Recent Developments
5.10 Ebb Therapeutics
5.10.1 Ebb Therapeutics Profile
5.10.2 Ebb Therapeutics Main Business
5.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Products, Services and Solutions
5.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Ebb Therapeutics Recent Developments
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Therapeutics Drugs Market Dynamics
11.1 Insomnia Therapeutics Drugs Industry Trends
11.2 Insomnia Therapeutics Drugs Market Drivers
11.3 Insomnia Therapeutics Drugs Market Challenges
11.4 Insomnia Therapeutics Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
